Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations
- PMID: 12609507
- DOI: 10.1016/s0960-8966(02)00271-7
Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations
Abstract
Desmin myopathy is a familial or sporadic disorder characterized by the presence of desmin mutations that cause skeletal muscle weakness associated with cardiac conduction block, arrhythmia and heart failure. Distinctive histopathologic features include intracytoplasmic accumulation of desmin-reactive deposits and electron-dense granular aggregates in skeletal and cardiac muscle cells. We describe two families with features of adult-onset slowly progressive skeletal myopathy without cardiomyopathy. N342D point mutation was present in the desmin helical rod domain in patients of family 1, and I451M mutation was found in the non-helical tail domain in patients of family 2. Of interest, the same I451M mutation has previously been reported in patients with cardiomyopathy and no signs of skeletal myopathy. Some carriers of the I451M mutation did not develop any disease, suggesting incomplete penetrance. Expression studies demonstrated inability of the N342D mutant desmin to form cellular filamentous network, confirming the pathogenic role of this mutation, but the network was not affected by the tail-domain I451M mutation. Progressive skeletal myopathy is a rare phenotypic variant of desmin myopathy allelic to the more frequent cardio-skeletal form.
Similar articles
-
Missense mutations in desmin associated with familial cardiac and skeletal myopathy.Nat Genet. 1998 Aug;19(4):402-3. doi: 10.1038/1300. Nat Genet. 1998. PMID: 9697706
-
Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.N Engl J Med. 2000 Mar 16;342(11):770-80. doi: 10.1056/NEJM200003163421104. N Engl J Med. 2000. PMID: 10717012
-
Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation.Int J Cardiol. 2007 Apr 25;117(2):244-53. doi: 10.1016/j.ijcard.2006.05.019. Epub 2006 Aug 4. Int J Cardiol. 2007. PMID: 16890305
-
Desmin myopathy.Brain. 2004 Apr;127(Pt 4):723-34. doi: 10.1093/brain/awh033. Epub 2004 Jan 14. Brain. 2004. PMID: 14724127 Review.
-
Desmin-related myopathy.Clin Genet. 2011 Oct;80(4):354-66. doi: 10.1111/j.1399-0004.2010.01512.x. Epub 2010 Jul 21. Clin Genet. 2011. PMID: 20718792 Review.
Cited by
-
Two desmin gene mutations associated with myofibrillar myopathies in Polish families.PLoS One. 2014 Dec 26;9(12):e115470. doi: 10.1371/journal.pone.0115470. eCollection 2014. PLoS One. 2014. PMID: 25541946 Free PMC article.
-
Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.Orphanet J Rare Dis. 2014 Aug 1;9:121. doi: 10.1186/s13023-014-0121-9. Orphanet J Rare Dis. 2014. PMID: 25208129 Free PMC article.
-
Granulocyte-colony stimulating factor ameliorates di-ethylhexyl phthalate-induced cardiac muscle injury via stem cells recruitment, Desmin protein regulation, antifibrotic and antiapoptotic mechanisms.J Mol Histol. 2023 Aug;54(4):349-363. doi: 10.1007/s10735-023-10137-6. Epub 2023 Jul 10. J Mol Histol. 2023. PMID: 37428366 Free PMC article.
-
Dilated cardiomyopathy: from genes and molecules to potential treatments.Mol Cell Biochem. 2025 Aug;480(8):4549-4571. doi: 10.1007/s11010-025-05269-0. Epub 2025 Mar 29. Mol Cell Biochem. 2025. PMID: 40155570 Review.
-
Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches.J Neuromuscul Dis. 2017;4(1):1-15. doi: 10.3233/JND-160203. J Neuromuscul Dis. 2017. PMID: 28269794 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical